H
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Price:
1.58
CNY
Market Closed
Market Cap:
¥7.7B
Relative Value
The Relative Value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.48 CNY. Compared to the current market price of 1.58 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 65%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
4.48
CNY
Undervaluation 65%
H
Multiples Across Competitors
Competitors Multiples
Hubei Biocause Pharmaceutical Co Ltd Competitors
Hubei Biocause Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | P/B | ||||
|---|---|---|---|---|---|---|---|
| CN |
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
7.8B CNY | 0.2 | -10.1 | 0.4 | |
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
191.8B ZAR | 1.5 | 8.6 | 1.9 | |
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
1.2T CNY | 3.2 | 7 | 1.9 | |
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
166.1B ZAR | 1.9 | 17.8 | 2.5 | |
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
1.1T CNY | 1.3 | 7.9 | 1.1 | |
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
111.4B ZAR | 2.9 | 23.7 | 7.7 | |
| HK |
|
AIA Group Ltd
HKEX:1299
|
868.2B HKD | 4.3 | 18.3 | 2.7 | |
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
63.3B ZAR | 0.4 | 9.7 | 1.1 | |
| US |
|
Aflac Inc
NYSE:AFL
|
56.6B USD | 3.3 | 15.5 | 1.9 | |
| CA |
|
Manulife Financial Corp
TSX:MFC
|
77.1B CAD | 2 | 14.6 | 1.5 | |
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
4.9T INR | 0.5 | 9.2 | 3.4 |
P/S Multiple
P/E Multiple
P/B Multiple
